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Intravascular or cardiac endothelial lesions may become colonized during
bacteraemic episodes and lead to the development of bacterial endocarditis (BE). It
has therefore long been recommended that patients with known cardiac lesions
receive prophylactic antibiotics before undergoing procedures that might release
bacteria into the blood stream. Because clinical trials of antibiotic prophylaxis of
endocarditis cannot be conducted in humans for ethical as well as for statistical
reasons (Durack, 1985), the questions of which antibiotic, what dosage, and for
how long are a matter of controversy. Unfortunately, these questions can only be
studied in animals, with all the limitations that this type of approach brings with it.
However, animal experimental studies have helped in understanding the conditions
and, to some extent, the mode of action of antibiotics in preventing the
development of endocardial infection, thus allowing some rationale for devising
prophylactic recommendations for the various patients at risk of developing BE.
The animal model of endocarditis: observations on
prophylaxis in rabbits and rats
In 1970, Garrison and Freedman reported that insertion of a polyethylene catheter in
the rabbit heart led to development of small sterile vegetations at points of contact
between the catheter and endocardium. If staphylococci were placed in the lumen of
the catheter, staphylococcal endocarditis resulted. Modification of this model by
injecting organisms intravenously provided a suitable in-vivo system for examining the
efficacy of various antibiotic regimens for prophylaxis of endocarditis (Durack &
Pctersdorf, 1973). Under these circumstances, the time of onset of infective
endocarditis is known exactly. Another important advantage is that the incidence of
infection in untreated animals can be adjusted easily by altering the inoculum size; thus
the problem of very low infection rates in patients can be overcome in animals by
choosing an inoculum large enough to approximate the infective dose producing
disease in 90% of the animals (ID90) for the organism under investigation. Significant
differences among antibiotic regimens can then be demonstrated with manageable
numbers of animals in each group.
Durack & Petersdorf (1973) and Pelletier, Durack & Petersdorf (1975) have used the
rabbit model to test the efficacy of various prophylactic antibiotic regimens against BE
caused by streptococci. In these experiments, a catheter passed across the tricuspid or
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aortic valve produces sterile vegetations that serve as a nidus for microbial localization
and growth after intravenous injection of 108 cfu of a strain of viridans streptococcus.
Bacterial colonization of the catheter-induced vegetations was uniformly observed when
the animals were killed 24 h after injection. Thirty minutes prior to injection of
streptococci, various antibiotics were administered parenterally to evaluate their ability
to prevent colonization and growth of bacteria in the vegetations.
Following a similar technique, we have recently developed a model in rats that is
similar to the rabbit model (Heralef, Glauser & Freedman, 1982). Briefly, a
polyethylene catheter is inserted across the aortic valve through the right carotid
artery, resulting in the production of sterile valvular vegetations. Twenty-four hours
after catheterization, the tail vein is injected with a given bacterial inoculum of the test
organism. The animals are sacrificed at various time intervals after bacterial challenge,
quantitative blood cultures are drawn, the aortic vegetations excised, weighed,
homogenized, serially diluted and cultured. Culture plates are counted after 48 to 72 h
incubation.
Antibiotic prophylaxis is tested by injecting one group of animals with a given
dosage of the selected antibiotic 30 min before bacterial challenge. The dosages of the
various antibiotics tested in rabbits or rats are chosen to produce serum levels at the
time the organisms are injected similar to those in humans after a recommended oral
dose.
Experiments on prophylaxis in rabbits
Durack and his colleagues in their early rabbit experiments injected 108 cfu of viridans
group streptococci and enterococci iv, an inoculum size that produced endocarditis in
100% of the animals. In fact, this number of bacteria was probably 10 to 100 times
higher than the lowest infectious dose necessary to produce endocarditis in 90% of the
rabbits (ID90). Under these conditions, careful and extensive experiments, using
various doses of prophylactic antibiotics given for various length of time, suggested
that cell wall active antibiotics (the so called 'bactericidal' antibiotics) such as beta-
lactams or vancomycin, were necessary for successful prophylaxis. In contrast,
bacteriostatic antibiotics such as tetracycline, erythromycin or clindamycin failed to
provide protection. Synergistic combinations of /3-lactam and aminoglycoside were
superior to single drug alone. For most antibiotics tested as single drug regimens, only
prolonged serum levels such as those provided by long acting preparations were
successful (Durack & Petersdorf, 1973; Durack, Starkebaum & Petersdorf, 1977;
Pelletier et al., 1975; Southwick & Durack, 1974)). Thus, these observations in rabbits
strongly suggested that prophylaxis was mediated through bacterial killing and
influenced the recommendation of the American Heart Association in 1977 for the
prophylaxis of BE (Kaplin et al., 1977), which suggested the parenteral administration
of antibiotics over 24-48 h, preferably in combination.
Experiments on prophylaxis in rats
(i) Prophylaxis of viridans streptococcal endocarditis. Using the rat model of
endocarditis, we first tested vancomycin for the prevention of endocarditis because it
had been shown in the rabbit model to be the only effective antibiotic given as a single
dose. In the rat, single dose vancomycin also prevented Streptococci^ sanguis
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endocarditis, but its efficacy was limited to rats challenged with a bacterial inoculum
size equal or inferior to the ID90, and vanished with higher inoculum sizes (Heraief,
Glauser & Freedman, 1980). Further experiments disclosed that this effect was
achieved in the absence of bacterial killing, since the S1. sanguis strain used was
demonstrated to be tolerant to vancomycin (Bernard, Francioli & Glauser, 1981). That
successful endocarditis prophylaxis could be achieved by mechanisms other than
bacterial killing was further demonstrated when clindamycin, and to a lesser degree
erythromycin, were also shown to prevent endocarditis induced by several viridans
streptococci in rats challenged with bacterial inoculum sizes equal to the ID90 (Glauser
& Francioli, 1982). Using single dose amoxycillin for prophylaxis, and streptococcal
strains of various susceptibilities to antibiotic killing for challenge, it became apparent
that single dose amoxycillin prophylaxis was successful against inoculum sizes higher
than the ID90, only when the strain was rapidly killed by the antibiotic. Indeed, for
single dose prophylaxis to be successful independently of the inoculum size, it
appeared that the bacteria had to be killed rapidly enough so that bacterial death
could occur during exposure to circulating antibiotic blood levels (Glauser et al.,
1983). Streptococcal strains with such a high level of sensitivity to killing by
amoxycillin or vancomycin are rarely encountered in patients with bacterial
endocarditis (Meylan, Francioli & Glauser, 1986). In contrast, when the bacteria were
not rapidly killed, or were tolerant to amoxycillin, the efficacy of single-dose
prophylaxis was limited to challenge with the ID90, and failed in animals challenged
with higher inoculum sizes. Similar observations were made after prophylaxis with
penicillin G (Francioli & Glauser, 1985). Even single doses of the synergistic
combination of amoxycillin plus gentamicin failed to protect against challenge with
such tolerant strains when using inoculum sizes higher than the ID90, possibly because
antibiotic blood levels were not sustained for long enough to completely eliminate the
bacteria that had attached to the vegetations (Francioli, Moreillon & Glauser, 1985).
Against such high bacterial challenge, only multiple doses of amoxycillin given at 6-
hourly intervals for 48 h after challenge were successful. Under these circumstances
multiple doses of the in-vitro synergistic combination of amoxycillin plus gentamicin
given at 6-hourly intervals was significantly superior to multiple doses of amoxycillin
alone, in that only one or two additional doses were necessary for successful
prophylaxis (Malinverni, Francioli & Glauser, 1986).
(ii) Prophylaxis of enterococcal endocarditis. Observations similar to those with
viridans streptococci were made in rats challenged with various strains of S. faecalis, a
bacterial species against which /Mactam antibiotics are notoriously bacteriostatic.
Indeed, single dose amoxycillin prophylaxis was successful against challenge with
inoculum sizes corresponding to the ID90, but not against higher inocula (Francioli et
al., 1985). It should be noted that the ID90 of all S. faecalis strains tested in this model
were 10- to 100-fold lower than those of the viridans streptococci tested (10* cfu/ml for
S. faecalis versus 105-107 cfu/ml for various viridans streptococci). The bactericidal
combination of amoxycillin plus gentamicin given as a single dose was not significantly
superior to the single dose of amoxycillin alone. In rats challenged with inoculum sizes
1000-10,000 higher than the ID90, only multiple doses of amoxycillin plus gentamicin
given at 6-hourly intervals for > 48 h were successful in preventing endocarditis, while
multiple doses of amoxycillin alone were not (Malinverni et al., 1986). This suggests
that bactericidal combinations were necessary to prevent enterococcal endocarditis
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induce by such high inocula, a known prerequisite for the treatment of established
enterococcal endocarditis.
Comparison of observations on endocarditis prophylaxis in rabbits and in rats
While experiments in rabbits established the need for the prolonged administration of
antibiotics (and preferably of the combination of synergistic antibiotics) to successfully
prevent endocarditis (suggesting bacterial killing as a mechanism of prophylaxis),
experiments in rats have shown that a single dose of antibiotic might prevent
endocarditis, even in the absence of bacterial killing. However, the systematic
observations in rats, using various inoculum sizes of each streptococcal strain tested,
have provided a rationale to reconcile these apparent contradictions. Indeed, as
previously mentioned, most experiments in rabbits have used an inoculum size for
challenge that was largely higher than the ID9 0 (Pelletier et ai., 1975), a condition
which has clearly been shown in rats to require multiple dose regimens for successful
prophylaxis unless the strain used for challenge is very sensitive to bacterial killing.
Summary of the experimental observations on the antibiotic prophylaxis of
streptococcal endocarditis
(a) Single doses of antibiotics such as amoxycillin, penicillin G, clindamycin (and to
a lesser degree erythromycin) and vancomycin are successful in reliably preventing
endocarditis induced by bacterial inocula corresponding to the ID90.
(b) single doses of such antibiotics fail against bacterial challenges higher than the
ID90 , unless the strain is exquisitely sensitive to bacterial killing, a rare phenomenon.
(c) Single doses of the synergistic combination of amoxycillin plus gentamicin are
not superior to amoxycillin alone in animals challenged with inoculum sizes higher
than the ID90.
(d) To overcome this limited efficacy, multiple doses of amoxycillin alone for
viridans streptococci and of amoxycillin plus gentamicin for enterococci, are necessary.
Relevance of the experimental model of endocarditis to the study of prophylaxis
There are three main objections to the animal model. The first objection is that it is an
animal model; the second is the presence of the intra-cardiac catheter, and the third is
the high bacterial inoculum used for challenge, which far exceeds those observed in
humans after dental or urogenital procedures.
The animal model of endocarditis for the study of antibiotic prophylaxis
As clearly pointed out by Durack (1985), a controlled clinical study of endocarditis
prophylaxis in human would be extremely difficult to perform. Indeed, ethical reasons
would preclude the use of a placebo group of patients and the low frequency of
developing endocarditis would require too large of a number of patients to be enrolled.
Thus, the animal model becomes a realistic approach to clarify some of the conditions
for successful endocarditis prophylaxis, and, more importantly, to help understand the
mode of action of prophylactic antibiotics. There is little doubt that antibiotics prevent
endocarditis in vivo by multifactorial mechanisms that are more complex than the
simple pharmacokinetic behaviour of antibiotics in humans or the killing of bacteria as
observed in the test tube.
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The presence of the intracardiac catheter
In most experimental studies the catheter has been left in situ for the duration of the
experiment, while there is usually no intravascular foreign body present in humans.
There is experimental evidence however that the persistance of the catheter worsens the
course of endocarditis (Perlman & Freedman, 1971; Francioli & Freedman, 1979) and
redijces the effectiveness of antibiotic prophylaxis (Heraief et al., 1980). Thus,
experimental models for the prophylaxis of endocarditis with a catheter in place
provide a very stringent test of an antibiotic to prevent infection of the cardiac
vegetations, possibly giving a margin of safety when recommended in humans.
Furthermore, the presence of a plastic catheter mimics the clinical situation of patients
with prosthetic heart valves or other intravascular foreign bodies.
The high number of bacteria used for challenge
The magnitude of the bacterial inocula injected iv to the animal (10*—108 cfu) has been
considered unrealistic when compared with bacteraemia observed in humans after
dental procedures. Indeed, the magnitude of bacteraemia observed in man after certain
procedures such as dental extractions is generally of the order of lO'-lO2 cfu/ml of
blood for a given strain (Everett & Hischmann, 1977). However, it should be stressed
that the number of bacteria injected iv to animals do not represent the number of
bacteria that circulate, and that the bacterial numbers found in the heart of the
animals after iv injections are far below the original inoculum, thanks to both a passive
haemodilution phenomenon and an active clearance mechanism by the reticulo-
endothelial system (Bernard et al., 1981).
In addition, the relationship between the magnitude of the bacteraemia and the
subsequent risk of developing endocarditis is unknown in humans. It might well be
that those very few patients who develop endocarditis after dental procedures are
precisely those with the highest numbers of circulating bacteria.
Lastly, recent studies on the production of endocarditis in rats after the extraction of
periodontally diseased teeth have failed to demonstrate a relationship between the
number of a given streptococcal species circulating immediately after dental extraction,
and the likelihood for these streptococci to subsequently produce endocarditis
(Moreillon et al., 1985). Indeed, some streptococcal strains found in the blood at
barely detectable levels, consistently produced endocarditis, while other viridans
streptococci detected in much higher numbers in the blood only rarely infected the
valves. In these experiments, the parameter that best predicted the likelihood to
produce endocarditis was the in-vitro stickiness of a given bacterial species for platelet-
fibrin matrices. Thus, the determination of the magnitude of bacteraemia alone after
certain procedures might not provide reliable information on the risk for the
subsequent development of BE.
Conclusions
The model of endocarditis both in rabbits and in rats has permitted extensive and
systematic study of the various important parameters in animals when endocarditis is
induced: firstly, the traumatized valvular endothelium necessary to induce such lesions;
secondly, the bacterial strains and their virulence factors; and thirdly, with regard to
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prophylaxis, the efficiency of numerous antibiotic regimens in preventing endocarditis
under various conditions. Our present understanding indicates that single doses of
several antibiotics arc successful in preventing streptococcal endocarditis, but have
limited efficacy. Under stringent conditions the best margin of safety is provided by
multiple doses of amoxycillin (or penicillin) for viridans streptococci, and multiple
doses of amoxycillin plus gentamicin for enterococci.
It is unlikely that a clinical trial of endocarditis prophylaxis will ever be performed
in patients. Thus, the observations made in the animal model of endocarditis represent
one useful approach in understanding the conditions necessary for successful
endocarditis prophylaxis, and assist the physician and the dentist in recommending
effective prophylactic regimens.
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